Skip to main content
Article
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome.
Biology of Blood and Marrow Transplantation (2014)
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Andrew T. Shields, University of Washington
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Mohamed L. Sorror, Fred Hutchinson Cancer Research Center
  • Hans Joachim Deeg, Fred Hutchinson Cancer Research Center
  • Rainer Storb, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
January 9, 2014
DOI
10.1016/j.bbmt.2014.05.014
Citation Information
Raya Mawad, Ted A. Gooley, Joseph G. Rajendran, Darrell R. Fisher, et al.. "Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome." Biology of Blood and Marrow Transplantation Vol. 20 Iss. 9 (2014) p. 1363 - 1368
Available at: http://works.bepress.com/john-pagel/109/